SCHEMBL30903294

SCHEMBL30903294

COc1cccc(CN[C@@H](CCC(C)(C)C)C(=O)O)c1C

nearest known ligand 0.50

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ITGA4 P13612 1/20 0.50
ITGB7 P26010 1/20 0.50
CD274 Q9NZQ7 14/20 0.47
PDCD1 Q15116 13/20 0.47
OPRK1 P41145 1/20 0.43
ALDH1A1 P00352 2/20 0.42
GAA P10253 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29213353 1.00 ITGA4 (0.50) ITGA4ITGB7CD274PDCD1OPRK1
SCHEMBL29213356 1.00 ITGA4 (0.50) ITGA4ITGB7CD274PDCD1OPRK1
SCHEMBL29213270 0.88 ALDH1A1 (0.56) ITGA4ITGB7CD274PDCD1ALDH1A1
SCHEMBL29213274 0.88 ALDH1A1 (0.56) ITGA4ITGB7CD274PDCD1ALDH1A1
Hydrochloric Acid SCHEMBL29213454 0.88 ITGA4 (0.61) ITGA4ITGB7CD274PDCD1ALDH1A1
Hydrochloric Acid SCHEMBL29213451 0.88 ITGA4 (0.61) ITGA4ITGB7CD274PDCD1ALDH1A1
SCHEMBL29213338 0.87 ITGA4 (0.49) ITGA4ITGB7CD274PDCD1ALDH1A1
SCHEMBL29213342 0.87 ITGA4 (0.49) ITGA4ITGB7CD274PDCD1ALDH1A1
Hydrochloric Acid SCHEMBL29213457 0.86 ITGA4 (0.48) ITGA4ITGB7CD274PDCD1ALDH1A1
SCHEMBL29213425 0.85 PDCD1 (0.41) ITGA4ITGB7CD274PDCD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118019533-A 2-Amino-5, 5-dimethylhexanoic acid derivatives as sortilin modulators for the treatment of central nervous system diseases 因苏森斯有限公司 2024-05-10 CN claimed
CN-118019533-A 2-Amino-5, 5-dimethylhexanoic acid derivatives as sortilin modulators for the treatment of central nervous system diseases 因苏森斯有限公司 2024-05-10 CN disclosed